NATCO Pharma Limited (BOM:524816)
India
· Delayed Price · Currency is INR 933.60
-15.25 (-1.61%)
At close: Dec 5, 2025
NATCO Pharma Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| Market Capitalization | 167,217 | 143,064 | 170,522 | 102,795 | 138,013 | 150,529 | Upgrade
|
| Market Cap Growth | -31.13% | -16.10% | 65.89% | -25.52% | -8.31% | 63.54% | Upgrade
|
| Enterprise Value | 137,825 | 120,583 | 160,841 | 93,605 | 133,992 | 144,005 | Upgrade
|
| Last Close Price | 933.60 | 794.44 | 943.10 | 552.58 | 735.80 | 797.51 | Upgrade
|
| PE Ratio | 10.87 | 7.59 | 12.28 | 14.37 | 81.18 | 34.14 | Upgrade
|
| PS Ratio | 3.81 | 3.23 | 4.26 | 3.80 | 7.09 | 7.32 | Upgrade
|
| PB Ratio | 1.93 | 1.88 | 2.91 | 2.11 | 3.24 | 3.65 | Upgrade
|
| P/TBV Ratio | 1.99 | 1.95 | 3.01 | 2.19 | 3.34 | 3.66 | Upgrade
|
| P/FCF Ratio | 12.50 | 11.04 | 19.55 | 14.63 | - | 340.56 | Upgrade
|
| P/OCF Ratio | 9.55 | 8.43 | 14.07 | 12.11 | 296.80 | 50.38 | Upgrade
|
| EV/Sales Ratio | 3.14 | 2.72 | 4.02 | 3.46 | 6.89 | 7.00 | Upgrade
|
| EV/EBITDA Ratio | 8.16 | 5.62 | 9.19 | 9.68 | 51.54 | 23.74 | Upgrade
|
| EV/EBIT Ratio | 9.27 | 6.13 | 10.24 | 11.56 | 108.58 | 29.19 | Upgrade
|
| EV/FCF Ratio | 10.30 | 9.31 | 18.44 | 13.32 | - | 325.80 | Upgrade
|
| Debt / Equity Ratio | 0.03 | 0.04 | 0.07 | 0.04 | 0.10 | 0.07 | Upgrade
|
| Debt / EBITDA Ratio | 0.15 | 0.13 | 0.22 | 0.18 | 1.64 | 0.47 | Upgrade
|
| Debt / FCF Ratio | 0.20 | 0.22 | 0.44 | 0.25 | - | 6.42 | Upgrade
|
| Asset Turnover | 0.47 | 0.57 | 0.64 | 0.50 | 0.39 | 0.44 | Upgrade
|
| Inventory Turnover | 0.97 | 0.89 | 0.94 | 0.78 | 0.66 | 0.66 | Upgrade
|
| Quick Ratio | 2.90 | 4.07 | 2.73 | 2.47 | 2.02 | 2.48 | Upgrade
|
| Current Ratio | 4.10 | 5.59 | 4.14 | 4.39 | 3.50 | 4.46 | Upgrade
|
| Return on Equity (ROE) | 19.44% | 27.97% | 25.88% | 15.66% | 4.05% | 11.19% | Upgrade
|
| Return on Assets (ROA) | 9.96% | 15.82% | 15.63% | 9.40% | 1.56% | 6.57% | Upgrade
|
| Return on Capital (ROIC) | 11.42% | 17.39% | 17.39% | 10.39% | 1.69% | 7.24% | Upgrade
|
| Return on Capital Employed (ROCE) | 17.00% | 25.60% | 26.50% | 16.30% | 2.80% | 11.60% | Upgrade
|
| Earnings Yield | 9.20% | 13.18% | 8.14% | 6.96% | 1.23% | 2.93% | Upgrade
|
| FCF Yield | 8.00% | 9.06% | 5.12% | 6.84% | -1.35% | 0.29% | Upgrade
|
| Dividend Yield | 0.37% | 0.76% | 1.01% | 1.00% | 0.61% | 0.66% | Upgrade
|
| Payout Ratio | 4.07% | 5.72% | 12.30% | 14.04% | 48.35% | 25.83% | Upgrade
|
| Buyback Yield / Dilution | -0.00% | 0.21% | 1.67% | -0.08% | 0.04% | -0.02% | Upgrade
|
| Total Shareholder Return | 0.37% | 0.97% | 2.68% | 0.92% | 0.66% | 0.64% | Upgrade
|
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.